(02196-hk) plans to increase capital of 10.2 million yuan to zhuorei clinic. In addition, ITP was approved by the National Bureau of immunotherapy for chronic thrombocytopenia. Kangfangbio (09926-hk) PD-1 / CTLA-4 double antibody ak104 in the treatment of advanced cervical cancer was qualified by FDA rapid approval channel. < p > < p > Hang Seng index released a quarterly inspection announcement, including Yaoming biological (02269-hk) into the Hang Seng Index, and a number of biotechnology companies such as kangfang biology and Kangning Jierui (09966-hk) were included in the Hang Seng Composite Index. The center for drug evaluation (CDE) issued the technical guidelines for the development of new coronal vaccines, which required that the protective efficacy of vaccines should not be less than 50%, and at least six months of protection should be provided. < p > < p > after the stock price adjustment of biotechnology sector, valuation attracted. In the academic conference in the second half of the year, many companies will update the clinical data of the products under development, which is expected to become a plate catalyst. The Bank recommends focusing on related enterprises, including kangfang biological (buy).